Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
significant new » significant non (Expand Search), significant anti (Expand Search), significant degs (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant changes (Expand Search)
significant new » significant non (Expand Search), significant anti (Expand Search), significant degs (Expand Search)
-
1561
Most common symptoms and frequency of appearance among IgG-positive patients.
Published 2025Subjects: -
1562
-
1563
-
1564
Characteristics of patients with <i>ACE2ACE2</i> and <i>TMPRSS2</i> expression.
Published 2025Subjects: -
1565
Myocardial <i>Shroom3</i> loss during development does not show abnormal semilunar valves.
Published 2025Subjects: -
1566
-
1567
-
1568
-
1569
Myocardial <i>Shroom3</i> loss during development does not show ventricular septal defects.
Published 2025Subjects: -
1570
-
1571
-
1572
Myocardial <i>Shroom3</i> loss during development does not alter ventricular wall thickness.
Published 2025Subjects: -
1573
Embryonic <i>Shroom3</i><sup><i>Gt</i>/<i>Gt</i></sup> hearts show ventricular septal defects.
Published 2025Subjects: -
1574
<i>Shroom3</i> is expressed throughout the mouse myocardium during cardiogenesis.
Published 2025Subjects: -
1575
-
1576
-
1577
-
1578
-
1579
Embryonic <i>Shroom3</i><sup><i>Gt</i>/<i>Gt</i></sup> hearts show left ventricular thinning.
Published 2025Subjects: -
1580
Embryonic <i>Shroom3</i><sup><i>Gt</i>/<i>Gt</i></sup> hearts show abnormal semilunar valves.
Published 2025Subjects: